Lubricating cell signaling pathways with gangliosides

Current Opinion in Structural Biology

Volumn 12, Issue 5, 2002, Pages 587-592

  Allende, Maria Laura ^a   Proia, Richard L ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; GANGLIOSIDE; GLYCOSPHINGOLIPID; INSULIN RECEPTOR; MYELIN ASSOCIATED GLYCOPROTEIN; SIALIC ACID; SIALIDASE; TYROSINE KINASE RECEPTOR;

CELL DIFFERENTIATION; CELL LEVEL; CELL MEMBRANE; EMBRYO DEVELOPMENT; HUMAN; LIPID DEGRADATION; LIPOGENESIS; NERVE REGENERATION; NERVOUS SYSTEM FUNCTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION;

EID: 0036816141     PISSN: 0959440X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-440X(02)00376-7     Document Type: Review

References (56)

1. Kolter T., Proia R.L., Sandhoff K. Combinatorial ganglioside biosynthesis. J Biol Chem. 277:2002;25859-25862.
2. Simons K., Toomre D. Lipid rafts and signal transduction. Nat Rev Mol Cell Biol. 1:2000;31-39.
3. Hakomori S. Inaugural article: the glycosynapse. Proc Natl Acad Sci USA. 99:2002;225-232. This paper, together with [4], describes some of the principal conceptual advances of glycosphingolipid function, many of which were made by this author.
4. Hakomori S. Traveling for the glycosphingolipid path. Glycoconj J. 17:2000;627-647.
5. Marks D.L., Dominguez M., Wu K., Pagano R.E. Identification of active site residue in glucosylceramide synthase. A nucleotide-binding catalytic motif conserved with processive β-glycosyltransferases. J Biol Chem. 276:2001;26492-26498.
6. Sprong H., Degroote S., Claessens T., van Drunen J., Oorschot V., Westerink B.H., Hirabayashi Y., Klumperman J., van der Sluijs P., van Meer G. Glycosphingolipids are required for sorting melanosomal proteins in the Golgi complex. J Cell Biol. 155:2001;369-380. This work outlines a novel function for glucosylceramide - the intracellular transport of proteins to melanosomes.
7. Giraudo C.G., Daniotti J.L., Maccioni H.J. Physical and functional association of glycolipid N-acetyl-galactosaminyl and galactosyl transferases in the Golgi apparatus. Proc Natl Acad Sci USA. 98:2001;1625-1630. Using FRET (fluorescence resonance energy transfer), two glycosyltransferases that function sequentially are found in a physical complex in the Golgi apparatus.
8. Lannert H., Gorgas K., Meissner I., Wieland F.T., Jeckel D. Functional organization of the Golgi apparatus in glycosphingolipid biosynthesis. Lactosylceramide and subsequent glycosphingolipids are formed in the lumen of the late Golgi. J Biol Chem. 273:1998;2939-2946.
9. Giraudo C.G., Rosales Fritz V.M., Maccioni H.J. GA2/GM2/GD2 synthase localizes to the trans-Golgi network of CHO-K1 cells. Biochem J. 342:1999;633-640.
10. Allende M.L., Li J., Darling D.S., Worth C.A., Young W.W. Jr. Evidence supporting a late Golgi location for lactosylceramide to ganglioside GM3 conversion. Glycobiology. 10:2000;1025-1032.
11. Simons M., Friedrichson T., Schulz J.B., Pitto M., Masserini M., Kurzchalia T.V. Exogenous administration of gangliosides displaces GPI-anchored proteins from lipid microdomains in living cells. Mol Biol Cell. 10:1999;3187-3196.
12. Kasahara K., Watanabe Y., Yamamoto T., Sanai Y. Association of Src family tyrosine kinase Lyn with ganglioside GD3 in rat brain. Possible regulation of Lyn by glycosphingolipid in caveolae-like domains. J Biol Chem. 272:1997;29947-29953.
13. Kasahara K., Watanabe K., Takeuchi K., Kaneko H., Oohira A., Yamamoto T., Sanai Y. Involvement of gangliosides in glycosylphosphatidylinositol-anchored neuronal cell adhesion molecule TAG-1 signaling in lipid rafts. J Biol Chem. 275:2000;34701-34709.
14. Prinetti A., Prioni S., Chigorno V., Karagogeos D., Tettamanti G., Sonnino S. Immunoseparation of sphingolipid-enriched membrane domains enriched in Src family protein tyrosine kinases and in the neuronal adhesion molecule TAG-1 by anti-GD3 ganglioside monoclonal antibody. J Neurochem. 78:2001;1162-1167.
15. Werth N., Schuette C.G., Wilkening G., Lemm T., Sandhoff K. Degradation of membrane-bound ganglioside GM2 by β-hexosaminidase A. Stimulation by GM2 activator protein and lysosomal lipids. J Biol Chem. 276:2001;12685-12690.
16. Tifft C.J., Proia R.L. Stemming the tide: glycosphingolipid synthesis inhibitors as therapy for storage diseases. Glycobiology. 10:2000;1249-1258.
17. Platt F.M., Neises G.R., Reinkensmeier G., Townsend M.J., Perry V.H., Proia R.L., Winchester B., Dwek R.A., Butters T.D. Prevention of lysosomal storage in Tay-Sachs mice treated with N-butyldeoxynojirimycin. Science. 276:1997;428-431.
18. Abe A., Gregory S., Lee L., Killen P.D., Brady R.O., Kulkarni A., Shayman J.A. Reduction of globotriaosylceramide in Fabry disease mice by substrate deprivation. J Clin Invest. 105:2000;1563-1571.
19. Liu Y., Wada R., Kawai H., Sango K., Deng C., Tai T., McDonald M.P., Araujo K., Crawley J.N., Bierfreund U., et al. A genetic model of substrate deprivation therapy for a glycosphingolipid storage disorder. J Clin Invest. 103:1999;497-505.
20. Yamashita T., Wada R., Sasaki T., Deng C., Bierfreund U., Sandhoff K., Proia R.L. A vital role for glycosphingolipid synthesis during development and differentiation. Proc Natl Acad Sci USA. 96:1999;9142-9147.
21. Takamiya K., Yamamoto A., Furukawa K., Yamashiro S., Shin M., Okada M., Fukumoto S., Haraguchi M., Takeda N., Fujimura K., et al. Mice with disrupted GM2/GD2 synthase gene lack complex gangliosides but exhibit only subtle defects in their nervous system. Proc Natl Acad Sci USA. 93:1996;10662-10667.
22. Sheikh K.A., Sun J., Liu Y., Kawai H., Crawford T.O., Proia R.L., Griffin J.W., Schnaar R.L. Mice lacking complex gangliosides develop Wallerian degeneration and myelination defects. Proc Natl Acad Sci USA. 96:1999;7532-7537.
23. Chiavegatto S., Sun J., Nelson R.J., Schnaar R.L. A functional role for complex gangliosides: motor deficits in GM2/GD2 synthase knockout mice. Exp Neurol. 166:2000;227-234.
24. Wu G., Xie X., Lu Z.H., Ledeen R.W. Cerebellar neurons lacking complex gangliosides degenerate in the presence of depolarizing levels of potassium. Proc Natl Acad Sci USA. 98:2001;307-312.
25. Kawai H., Allende M.L., Wada R., Kono M., Sango K., Deng C., Miyakawa T., Crawley J.N., Werth N., Bierfreund U., et al. Mice expressing only monosialoganglioside GM3 exhibit lethal audiogenic seizures. J Biol Chem. 276:2001;6885-6888. This paper, together with [27], shows that gangliosides are essential for proper functioning of the nervous system.
26. Okada M., Itoh Mi M., Haraguchi M., Okajima T., Inoue M., Oishi H., Matsuda Y., Iwamoto T., Kawano T., Fukumoto S., et al. b-Series ganglioside deficiency exhibits no definite changes in the neurogenesis and the sensitivity to Fas-mediated apoptosis but impairs regeneration of the lesioned hypoglossal nerve. J Biol Chem. 277:2002;1633-1636.
27. Inoue M., Fujii Y., Furukawa K., Okada M., Okumura K., Hayakawa T., Sugiura Y. Refractory skin injury in the complex knock-out mice expressing only GM3 ganglioside. J Biol Chem. 277:2002;29881-29888.
28. Bremer E.G., Schlessinger J., Hakomori S. Ganglioside-mediated modulation of cell growth. Specific effects of GM3 on tyrosine phosphorylation of the epidermal growth factor receptor. J Biol Chem. 261:1986;2434-2440.
29. Rebbaa A., Hurh J., Yamamoto H., Kersey D.S., Bremer E.G. Ganglioside GM3 inhibition of EGF receptor mediated signal transduction. Glycobiology. 6:1996;399-406.
30. Farooqui T., Kelley T., Coggeshall K.M., Rampersaud A.A., Yates A.J. GM1 inhibits early signaling events mediated by PDGF receptor in cultured human glioma cells. Anticancer Res. 19:1999;5007-5013.
31. Meuillet E.J., Kroes R., Yamamoto H., Warner T.G., Ferrari J., Mania-Farnell B., George D., Rebbaa A., Moskal J.R., Bremer E.G. Sialidase gene transfection enhances epidermal growth factor receptor activity in an epidermoid carcinoma cell line, A431. Cancer Res. 59:1999;234-240.
32. Li R., Manela J., Kong Y., Ladisch S. Cellular gangliosides promote growth factor-induced proliferation of fibroblasts. J Biol Chem. 275:2000;34213-34223.
33. Meuillet E.J., Mania-Farnell B., George D., Inokuchi J.I., Bremer E.G. Modulation of EGF receptor activity by changes in the GM3 content in a human epidermoid carcinoma cell line, A431. Exp Cell Res. 256:2000;74-82.
34. Zurita A.R., Maccioni H.J., Daniotti J.L. Modulation of epidermal growth factor receptor phosphorylation by endogenously expressed gangliosides. Biochem J. 355:2001;465-472.
35. Mitsuda T., Furukawa K., Fukumoto S., Miyazaki H., Urano T. Overexpression of ganglioside GM1 results in the dispersion of platelet-derived growth factor receptor from glycolipid-enriched microdomains and in the suppression of cell growth signals. J Biol Chem. 277:2002;11239-11246.
36. Roepstorff K., Thomsen P., Sandvig K., Van Deurs B. Sequestration of epidermal growth factor receptors in non-caveolar lipid rafts inhibits ligand binding. J Biol Chem. 277:2002;18954-18960.
37. Rusnati M., Urbinati C., Tanghetti E., Dell'Era P., Lortat-Jacob H., Presta M. Cell membrane GM1 ganglioside is a functional coreceptor for fibroblast growth factor 2. Proc Natl Acad Sci USA. 99:2002;4367-4372.
38. Zeng G., Gao L., Suetake K., Joshi R.M., Yu R.K. Variations in gene expression patterns correlated with phenotype of F-11 tumor cells whose expression of GD3-synthase is suppressed. Cancer Lett. 178:2002;91-98.
39. Meuillet E., Cremel G., Hicks D., Dreyfus H. Ganglioside effects on basic fibroblast and epidermal growth factor receptors in retinal glial cells. J Lipid Mediat Cell Signal. 14:1996;277-288.
40. Miljan E.A., Meuillet E.J., Mania-Farnell B., George D., Yamamoto H., Simon H.G., Bremer E.G. Interaction of the extracellular domain of the epidermal growth factor receptor with gangliosides. J Biol Chem. 277:2002;10108-10113. The authors describe a mechanism for the modulation of EGF receptor signaling by gangliosides.
41. Wang X.Q., Sun P., O'Gorman M., Tai T., Paller A.S. Epidermal growth factor receptor glycosylation is required for ganglioside GM3 binding and GM3-mediated suppression of activation. Glycobiology. 11:2001;515-522.
42. Tagami S., Inokuchi Ji J., Kabayama K., Yoshimura H., Kitamura F., Uemura S., Ogawa C., Ishii A., Saito M., Ohtsuka Y., et al. Ganglioside GM3 participates in the pathological conditions of insulin resistance. J Biol Chem. 277:2002;3085-3092. This work presents an intriguing link between type 2 diabetes and expression of the GM3 ganglioside.
43. Miyagi T., Wada T., Iwamatsu A., Hata K., Yoshikawa Y., Tokuyama S., Sawada M. Molecular cloning and characterization of a plasma membrane-associated sialidase specific for gangliosides. J Biol Chem. 274:1999;5004-5011.
44. Kalka D., von Reitzenstein C., Kopitz J., Cantz M. The plasma membrane ganglioside sialidase cofractionates with markers of lipid rafts. Biochem Biophys Res Commun. 283:2001;989-993. See annotation to [45•].
45. Wang Y., Yamaguchi K., Wada T., Hata K., Zhao X., Fujimoto T., Miyagi T. A close association of ganglioside-specific sialidase, Neu 3, with caveolin in membrane microdomains. J Biol Chem. 14:2002;14. Together with [44•], this paper shows an association of a ganglioside-specific sialidase with caveolae (and rafts). The results suggest that dynamic ganglioside changes may occur in microdomains.
46. Wang X., Rahman Z., Sun P., Meuillet E., George D., Bremer E.G., Al-Qamari A., Paller A.S. Ganglioside modulates ligand binding to the epidermal growth factor receptor. J Invest Dermatol. 116:2001;69-76.
47. Fruttiger M., Montag D., Schachner M., Martini R. Crucial role for the myelin-associated glycoprotein in the maintenance of axon-myelin integrity. Eur J Neurosci. 7:1995;511-515.
48. McKerracher L., David S., Jackson D.L., Kottis V., Dunn R.J., Braun P.E. Identification of myelin-associated glycoprotein as a major myelin-derived inhibitor of neurite growth. Neuron. 13:1994;805-811.
49. Mukhopadhyay G., Doherty P., Walsh F.S., Crocker P.R., Filbin M.T. A novel role for myelin-associated glycoprotein as an inhibitor of axonal regeneration. Neuron. 13:1994;757-767.
50. Schafer M., Fruttiger M., Montag D., Schachner M., Martini R. Disruption of the gene for the myelin-associated glycoprotein improves axonal regrowth along myelin in C57BL/Wlds mice. Neuron. 16:1996;1107-1113.
51. Yang L.J., Zeller C.B., Shaper N.L., Kiso M., Hasegawa A., Shapiro R.E., Schnaar R.L. Gangliosides are neuronal ligands for myelin-associated glycoprotein. Proc Natl Acad Sci USA. 93:1996;814-818.
52. Collins B.E., Ito H., Sawada N., Ishida H., Kiso M., Schnaar R.L. Enhanced binding of the neural siglecs, myelin-associated glycoprotein and Schwann cell myelin protein, to Chol-1 (α-series) gangliosides and novel sulfated Chol-1 analogs. J Biol Chem. 274:1999;37637-37643.
53. Collins B.E., Yang L.J., Mukhopadhyay G., Filbin M.T., Kiso M., Hasegawa A., Schnaar R.L. Sialic acid specificity of myelin-associated glycoprotein binding. J Biol Chem. 272:1997;1248-1255.
54. Yin X., Crawford T.O., Griffin J.W., Tu P., Lee V.M., Li C., Roder J., Trapp B.D. Myelin-associated glycoprotein is a myelin signal that modulates the caliber of myelinated axons. J Neurosci. 18:1998;1953-1962.
55. Vyas A.A., Patel H.V., Fromholt S.E., Heffer-Lauc M., Vyas K.A., Dang J., Schachner M., Schnaar R.L. From the cover: gangliosides are functional nerve cell ligands for myelin-associated glycoprotein (MAG), an inhibitor of nerve regeneration. Proc Natl Acad Sci USA. 99:2002;8412-8417. The authors show that gangliosides have an essential function in neuron-glia interactions by mediating the signal from MAG to control neurite growth.
56. NTR, which transmits the MAG signal across the neuronal plasma membrane to RhoA.